Oncosil Medical Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncosil Medical Ltd with three other companies in this sector in AUSTRALIA : Exopharm Ltd (2020 sales of 2.67 million Australian Dollars [US$2.05 million] ), Invion Limited (3.48 million Australian Dollars [US$2.68 million] of which 100% was Drug Development), and Bioxyne Limited (2.26 million Australian Dollars [US$1.74 million] ).

Sales Analysis. Sales levels dropped significantly in the second fiscal quarter of 2021 versus the previous year's second quarter. During the second fiscal quarter of 2021, sales at Oncosil Medical Ltd totalled A$682,843.00 . This is a drop of 44.2% from the A$1.22 million in sales at the company during the second quarter in 2020. During the year ended June of 2020, sales at Oncosil Medical Ltd were A$2.87 million (US$2.21 million). This is a sharp decrease of 25.1% versus 2019, when the company's sales were A$3.83 million. The sales level in 2020 was fairly close to the level five years ago: in 2015, Oncosil Medical Ltd had sales of A$3.03 million.